BioNTech SE

NASDAQ BNTX

Data sourced from iex and EODHD
Download Data

BioNTech SE Income Statement 2018 - 2024

This table shows the Income Statement for BioNTech SE going from 2018 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30
Revenue
M 188 1,479 895 168 1,277 4,278 3,461 3,197 6,375 5,533 6,087 5,309 2,048 345 67 42 28 28 29 26 26 64 20
Cost of Revenue
M 59 179 660 536 430 693 1,095 1,164 1,580 855 1,472 1,085 233 298 235 101 71 70 55 59 60 56 36
Gross Profit
M 129 1,300 236 -369 847 3,585 2,367 2,032 4,795 4,678 4,616 4,224 1,815 47 -167 -59 -43 -42 -26 -33 -34 8 -15
Operating Expenses
M 636 774 163 195 193 292 -21 -177 42 -22 -108 25 153 -197 19 22 16 11 11 15 10 10 6
Selling, General, and Administrative Expenses (SG&A)
M 117 131 136 123 119 123 141 130 91 128 66 47 39 29 23 17 15 6 11 13 8 8 7
Research and Development (R&D) Expenses
M 508 578 512 373 331 116 - - - 575 260 201 216 259 228 95 65 65 50 53 57 52 33
Other Operating Expenses
M 11 65 -486 -301 -257 53 - - - -725 -435 -222 -102 -485 -232 -91 -64 -61 -50 -52 -56 -50 -33
Costs and Expenses
M 577 523 -506 -342 -312 -401 -949 -1,054 -1,480 -749 -1,414 -1,025 -39 -488 -215 -79 -55 -59 -44 -44 -51 -46 -29
Operating Income
M -507 526 73 -563 654 3,293 2,388 2,210 4,753 4,700 4,724 4,198 1,662 244 -186 -81 -59 -53 -37 -48 -44 -2 -22
Interest Expense
M 5 19 2 1 102 159 4 6 4 3 1 1 1 24 22 10 1 0 1 3 0 0 2
Non-operating Income/Expense
M 175 -52 55 151 53 -120 57 110 265 159 110 -136 24 -39 -21 -10 6 -6 7 -2 3 6 0
EBT
M -332 663 227 -412 708 3,173 2,444 2,319 5,018 4,714 4,667 4,023 1,642 206 -208 -91 -53 -59 -30 -50 -41 -1 -23
Income Tax Provision
M -17 205 67 -222 206 894 659 647 1,319 1,548 1,456 1,236 514 -161 2 -2 0 0 0 0 0 0 1
Income after Tax
M -315 458 161 -190 502 2,279 1,785 1,672 3,699 3,166 3,211 2,787 1,128 367 -210 -88 -53 -58 -30 -50 -41 -1 -23
Non-Controlling Interest
M - - 0 -351 342 2,118 0 0 0 0 0 0 0 0 0 0 0 0 0 -20 0 29 -
Net Income
M - - 161 161 161 161 1,785 1,672 3,699 3,166 3,211 2,787 1,128 367 -210 -88 -53 -58 -30 -30 -41 -48 -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 240,534,351.00 241,874,910.00 239,701,492.00 239,771,156.00 244,975,609.00 246,079,914.00 255,716,332.00 259,224,806.00 259,747,191.00 259,700,000.00 260,000,000.00 258,792,943.00 256,970,387.00 248,500,000.00 240,785,575.00 232,368,421.00 222,500,000.00 211,500,000.00 229,462,336.00 229,462,336.00 226,859,216.00 226,859,216.00 226,859,216.00
EBITDA
M -289 507 216 -379 841 3,361 2,262 1,957 4,721 4,584 4,578 4,176 1,632 194 -177 -72 -44 -49 -21 -39 -33 7 -16
Depreciation and Amortization
M 38 79 41 32 186 68 -125 -253 -32 26 20 16 13 13 9 9 9 10 8 8 7 8 5
EBIT
M -327 429 174 -411 654 3,293 2,388 2,210 4,753 4,558 4,558 4,160 1,619 182 -186 -81 -53 -58 -30 -47 -40 -1 -21
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - 0 0 0 0 0 -
Tax Rate (Effective)
% 5.03 30.96 29.38 53.81 29.04 28.18 26.97 27.91 26.29 32.83 31.20 30.71 31.31 -78.44 -1.20 2.44 -0.01 0.51 -0.03 -0.03 -0.01 -1.17 -2.50
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% 68.50 87.89 26.32 -219.80 66.33 83.79 68.38 63.58 75.22 84.55 75.82 79.56 88.62 13.73 -247.69 -141.49 -156.53 -149.62 -90.59 -128.39 -131.12 11.77 -74.38
Operating Income Margin
% -270.36 35.58 8.16 -335.90 51.25 76.97 68.98 69.13 74.56 84.95 77.60 79.09 81.15 70.69 -276.29 -193.82 -214.28 -189.16 -128.65 -185.64 -167.60 -3.76 -106.04
Net Income Margin
% - - 17.94 95.77 12.58 3.75 51.57 52.31 58.02 57.23 52.75 52.50 55.07 106.22 -311.35 -211.43 -192.99 -208.03 -105.03 -116.75 -155.41 -75.29 -
EBITDA Ratio
% -153.94 34.31 24.09 -226.00 65.83 78.55 65.36 61.22 74.05 82.86 75.21 78.67 79.69 56.24 -262.55 -172.25 -160.02 -173.32 -73.57 -151.37 -126.45 11.26 -79.93
EBIT Ratio
% -174.36 28.98 19.48 -245.02 51.25 76.97 68.98 69.13 74.56 82.39 74.88 78.36 79.05 52.61 -275.59 -193.33 -191.09 -208.36 -103.20 -183.99 -153.92 -1.64 -104.37
EBT Ratio
% -176.87 44.84 25.40 -245.80 55.42 74.16 70.61 72.56 78.72 85.20 76.67 75.78 80.17 59.52 -307.66 -216.71 -192.96 -209.09 -105.00 -194.19 -155.83 -2.28 -112.30

StockViz Staff

September 16, 2024

Any question? Send us an email